15-100568921-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001040616.3(LINS1):c.*317A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.567 in 228,660 control chromosomes in the GnomAD database, including 37,975 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.56 ( 24201 hom., cov: 29)
Exomes 𝑓: 0.59 ( 13774 hom. )
Consequence
LINS1
NM_001040616.3 3_prime_UTR
NM_001040616.3 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.23
Genes affected
LINS1 (HGNC:30922): (lines homolog 1) The Drosophila segment polarity gene lin encodes a protein, lines, which plays important roles in development of the epidermis and hindgut. This gene encodes a protein containing a lines-like domain. This gene is located on chromosome 15 and clustered with the gene encoding ankyrin repeat and SOCS box-containing protein 7. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.01).
BP6
Variant 15-100568921-T-C is Benign according to our data. Variant chr15-100568921-T-C is described in ClinVar as [Benign]. Clinvar id is 1220592.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.635 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LINS1 | NM_001040616.3 | c.*317A>G | 3_prime_UTR_variant | 7/7 | ENST00000314742.13 | NP_001035706.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LINS1 | ENST00000314742.13 | c.*317A>G | 3_prime_UTR_variant | 7/7 | 5 | NM_001040616.3 | ENSP00000318423 | P1 | ||
LINS1 | ENST00000560783.1 | c.192-3656A>G | intron_variant, NMD_transcript_variant | 5 | ENSP00000474128 |
Frequencies
GnomAD3 genomes AF: 0.557 AC: 84447AN: 151578Hom.: 24187 Cov.: 29
GnomAD3 genomes
AF:
AC:
84447
AN:
151578
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.585 AC: 45062AN: 76966Hom.: 13774 Cov.: 0 AF XY: 0.582 AC XY: 24568AN XY: 42214
GnomAD4 exome
AF:
AC:
45062
AN:
76966
Hom.:
Cov.:
0
AF XY:
AC XY:
24568
AN XY:
42214
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.557 AC: 84510AN: 151694Hom.: 24201 Cov.: 29 AF XY: 0.557 AC XY: 41277AN XY: 74092
GnomAD4 genome
AF:
AC:
84510
AN:
151694
Hom.:
Cov.:
29
AF XY:
AC XY:
41277
AN XY:
74092
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1707
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 19, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at